Active Gastrointestinal and Other Cancers Grants

PI Name Organization - Company Title Major Program / Research Group FOAsort ascending
Lipkin, Steven M Weill Medical Coll Of Cornell Univ (PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance RFA-CA-17-017: Research Answers to NCI's Provocative Questions
WANG, TIMOTHY CRAGIN COLUMBIA UNIVERSITY HEALTH SCIENCES The Role of the Microenvironment in Barrett's Esophagus Barrett's Esophagus Translational Research Network RFA-CA-16-006:
Wang, Thomas D University Of Michigan At Ann Arbor Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma Barrett's Esophagus Translational Research Network RFA-CA-16-006: Research Centers for Barretts Esophagus Translational Research Network (BETRNet)
Chak, Amitabh Case Western Reserve University Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma Barrett's Esophagus Translational Research Network RFA-CA-16-006: Research Centers for Barretts Esophagus Translational Research Network (BETRNet)
Waldman, Scott A Thomas Jefferson University (PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation Provocative Questions RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Sepulveda, Antonia Rogado George Washington University Mechanisms and Genomics of Esophageal Carcinogenesis Provocative Questions RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Chan, Andrew T Massachusetts General Hospital Precision Prevention Research Program PAR-19-349: NCI Outstanding Investigator Award
Chang, Su-Hsin Washington University Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective PAR-19-279: Provocative Questions (PQs) in Multiple Myeloma Disparities Research
Chan, Andrew T Massachusetts General Hospital Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Allen, Peter J Duke University Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Smith, Jill P Georgetown University Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent PAR-18-020: NCI Clinical and Translational Exploratory/Developmental Studies
Markowitz, Sanford D. Case Western Reserve University Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment PAR-15-342: NCI Outstanding Investigator Award
Willis, Joseph Edward Case Western Reserve University Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus PAR-15-095: Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3)
Cao, Yin Washington University Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia PA-19-056: Research Project Grant

Pages